{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:08:33Z","timestamp":1789117713956,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"DOI":"10.1007\/s12325-026-03776-0","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:41:05Z","timestamp":1789116065000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparing Pneumonia Risks of Budesonide with Fluticasone Among Patients with Asthma in Hong Kong: A Territory-Wide Retrospective Study"],"prefix":"10.1007","author":[{"given":"Wang Chun","family":"Kwok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting Fung","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuk Man","family":"Ngai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Yau Hang","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence Chi Chun","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-5284","authenticated-orcid":false,"given":"James Chung Man","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"12","key":"3776_CR1","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1164\/rccm.201810-1868CI","volume":"199","author":"R Beasley","year":"2019","unstructured":"Beasley R, Harper J, Bird G, et al. Inhaled corticosteroid therapy in adult asthma. Time for a new therapeutic dose terminology. Am J Respir Crit Care Med. 2019;199(12):1471\u20137. https:\/\/doi.org\/10.1164\/rccm.201810-1868CI.","journal-title":"Am J Respir Crit Care Med"},{"key":"3776_CR2","unstructured":"Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention; 2024. (GINA guidelines), p. 37"},{"issue":"1","key":"3776_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-019-1025-1","volume":"19","author":"E Ekbom","year":"2019","unstructured":"Ekbom E, Quint J, Scholer L, et al. Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia. BMC Pulm Med. 2019;19(1):254. https:\/\/doi.org\/10.1186\/s12890-019-1025-1.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"3776_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jaip.2023.09.034","volume":"12","author":"H Kankaanranta","year":"2024","unstructured":"Kankaanranta H, Viinanen A, Ilmarinen P, et al. Comorbidity burden in severe and nonsevere asthma: a nationwide observational study (FINASTHMA). J Allergy Clin Immunol Pract. 2024;12(1):135-145 e9. https:\/\/doi.org\/10.1016\/j.jaip.2023.09.034.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"3776_CR5","doi-asserted-by":"publisher","unstructured":"Halpin DM, Gray J, Edwards SJ, Morais J, Singh D. Budesonide\/formoterol vs. salmeterol\/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials. Int J Clin Pract. 2011;65(7):764\u201374. https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02685.x","DOI":"10.1111\/j.1742-1241.2011.02685.x"},{"key":"3776_CR6","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2147\/COPD.S332151","volume":"16","author":"JH Choi","year":"2021","unstructured":"Choi JH, Jeong KB, Park YH, et al. Comparison of risk of pneumonia caused by fluticasone propionate versus budesonide in chronic obstructive pulmonary disease: a nationwide retrospective cohort study. Int J Chron Obstruct Pulmon Dis. 2021;16:3229\u201337. https:\/\/doi.org\/10.2147\/COPD.S332151.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3776_CR7","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.2147\/COPD.S139035","volume":"12","author":"HH Yang","year":"2017","unstructured":"Yang HH, Lai CC, Wang YH, et al. Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist. Int J Chron Obstruct Pulmon Dis. 2017;12:2477\u201385. https:\/\/doi.org\/10.2147\/COPD.S139035.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3776_CR8","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.2147\/COPD.S269637","volume":"15","author":"TP Lodise","year":"2020","unstructured":"Lodise TP, Li J, Gandhi HN, O\u2019Brien G, Sethi S. Intraclass difference in pneumonia risk with fluticasone and budesonide in COPD: a systematic review of evidence from direct-comparison studies. Int J Chron Obstruct Pulmon Dis. 2020;15:2889\u2013900. https:\/\/doi.org\/10.2147\/COPD.S269637.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"3776_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.18553\/jmcp.2016.22.3.293","volume":"22","author":"JR Davis","year":"2016","unstructured":"Davis JR, Kern DM, Williams SA, et al. Health care utilization and costs after initiating budesonide\/formoterol combination or fluticasone\/salmeterol combination among COPD patients new to ICS\/LABA treatment. J Manag Care Spec Pharm. 2016;22(3):293\u2013304. https:\/\/doi.org\/10.18553\/jmcp.2016.22.3.293.","journal-title":"J Manag Care Spec Pharm"},{"key":"3776_CR10","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). http:\/\/www.goldcopd.org. Accessed 25 Jan 2025."},{"issue":"9","key":"3776_CR11","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1111\/bcp.13295","volume":"83","author":"CJ Qian","year":"2017","unstructured":"Qian CJ, Coulombe J, Suissa S, Ernst P. Pneumonia risk in asthma patients using inhaled corticosteroids: a quasi-cohort study. Br J Clin Pharmacol. 2017;83(9):2077\u201386. https:\/\/doi.org\/10.1111\/bcp.13295.","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"3776_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1164\/rccm.201005-0694OC","volume":"183","author":"PM O\u2019Byrne","year":"2011","unstructured":"O\u2019Byrne PM, Pedersen S, Carlsson LG, et al. Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med. 2011;183(5):589\u201395. https:\/\/doi.org\/10.1164\/rccm.201005-0694OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Pt 2","key":"3776_CR13","first-page":"1183","volume":"107","author":"NT Cheung","year":"2004","unstructured":"Cheung NT, Fung V, Kong JH. The Hong Kong Hospital Authority\u2019s information architecture. Stud Health Technol Inform. 2004;107(Pt 2):1183\u20136.","journal-title":"Stud Health Technol Inform"},{"key":"3776_CR14","doi-asserted-by":"publisher","first-page":"315","DOI":"10.2147\/JAA.S405297","volume":"16","author":"WC Kwok","year":"2023","unstructured":"Kwok WC, Tam TCC, Sing CW, Chan EWY, Cheung CL. Validation of diagnostic coding for asthma in an electronic health record system in Hong Kong. J Asthma Allergy. 2023;16:315\u201321. https:\/\/doi.org\/10.2147\/JAA.S405297.","journal-title":"J Asthma Allergy"},{"issue":"10","key":"3776_CR15","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1136\/thoraxjnl-2015-206780","volume":"70","author":"A Torres","year":"2015","unstructured":"Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and\/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70(10):984\u20139. https:\/\/doi.org\/10.1136\/thoraxjnl-2015-206780.","journal-title":"Thorax"},{"key":"3776_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030218","author":"WC Kwok","year":"2025","unstructured":"Kwok WC, Wong JC, Cheung A, Tam TC. Vaccination in chronic obstructive pulmonary disease. Vaccines. 2025. https:\/\/doi.org\/10.3390\/vaccines13030218.","journal-title":"Vaccines"},{"key":"3776_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/5584_2015_206","volume":"910","author":"J Yayan","year":"2016","unstructured":"Yayan J, Rasche K. Asthma and COPD: similarities and differences in the pathophysiology, diagnosis and therapy. Adv Exp Med Biol. 2016;910:31\u20138. https:\/\/doi.org\/10.1007\/5584_2015_206.","journal-title":"Adv Exp Med Biol"},{"key":"3776_CR18","doi-asserted-by":"crossref","unstructured":"Yayan J, Rasche K. Asthma and COPD: similarities and differences in the pathophysiology, diagnosis and therapy. Respirat Med Sci. 2016;910:31\u201338.","DOI":"10.1007\/5584_2015_206"},{"issue":"3","key":"3776_CR19","doi-asserted-by":"publisher","first-page":"151","DOI":"10.4046\/trd.2022.0147","volume":"86","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Park YB. Inhaled corticosteroids is not associated with the risk of pneumonia in asthma. Tuberc Respir Dis (Seoul). 2023;86(3):151\u20137. https:\/\/doi.org\/10.4046\/trd.2022.0147.","journal-title":"Tuberc Respir Dis (Seoul)"},{"issue":"1","key":"3776_CR20","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S1081-1206(10)61285-9","volume":"94","author":"AL Sheffer","year":"2005","unstructured":"Sheffer AL, Silverman M, Woolcock AJ, et al. Long-term safety of once-daily budesonide in patients with early-onset mild persistent asthma: results of the Inhaled Steroid Treatment as Regular Therapy in Early Asthma (START) study. Ann Allergy Asthma Immunol. 2005;94(1):48\u201354. https:\/\/doi.org\/10.1016\/S1081-1206(10)61285-9.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"17","key":"3776_CR21","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.2165\/00003495-200666170-00006","volume":"66","author":"M Noonan","year":"2006","unstructured":"Noonan M, Rosenwasser LJ, Martin P, O\u2019Brien CD, O\u2019Dowd L. Efficacy and safety of budesonide and formoterol in one pressurised metered-dose inhaler in adults and adolescents with moderate to severe asthma: a randomised clinical trial. Drugs. 2006;66(17):2235\u201354. https:\/\/doi.org\/10.2165\/00003495-200666170-00006.","journal-title":"Drugs"},{"issue":"70","key":"3776_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta22700","volume":"22","author":"T McKeever","year":"2018","unstructured":"McKeever T, Mortimer K, Bradshaw L, et al. Temporarily quadrupling the dose of inhaled steroid to prevent asthma exacerbations: FAST. Health Technol Assess. 2018;22(70):1\u201382. https:\/\/doi.org\/10.3310\/hta22700.","journal-title":"Health Technol Assess"},{"key":"3776_CR23","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2147\/COPD.S175017","volume":"13","author":"SL Cheng","year":"2018","unstructured":"Cheng SL. Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:2775\u201384. https:\/\/doi.org\/10.2147\/COPD.S175017.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"3776_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2024.107843","volume":"234","author":"STE Buchardt","year":"2024","unstructured":"Buchardt STE, Weinreich UM, Lindgren FL, et al. Patient characteristics and mortality across diagnostic settings in COPD. Respir Med. 2024;234:107843. https:\/\/doi.org\/10.1016\/j.rmed.2024.107843.","journal-title":"Respir Med"},{"issue":"11","key":"3776_CR25","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/j.clinthera.2019.08.015","volume":"41","author":"K Sato","year":"2019","unstructured":"Sato K, Ohno T, Ishii T, Ito C, Kaise T. The prevalence, characteristics, and patient burden of severe asthma determined by using a Japan health care claims database. Clin Ther. 2019;41(11):2239\u201351. https:\/\/doi.org\/10.1016\/j.clinthera.2019.08.015.","journal-title":"Clin Ther"},{"issue":"9","key":"3776_CR26","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/thoraxjnl-2018-213035","volume":"74","author":"E Sapey","year":"2019","unstructured":"Sapey E, Bafadhel M, Bolton CE, et al. Building toolkits for COPD exacerbations: lessons from the past and present. Thorax. 2019;74(9):898\u2013905. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-213035.","journal-title":"Thorax"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03776-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03776-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T08:41:07Z","timestamp":1789116067000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03776-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":26,"alternative-id":["3776"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03776-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Wang Chun Kwok, Lu Zhou, Ting Fung Ma, Shuk Man Ngai, Raymond Yau Hang Leung, Terence Chi Chun Tam, and James Chung Man Ho declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the University of Hong Kong and Hospital Authority Hong Kong West Cluster (UW 23-510). Patient informed consent was waived by the Institutional Review Board of the University of Hong Kong and Hospital Authority Hong Kong West Cluster, as it was a retrospective study without active patient recruitment, and all retrieved clinical data were already de-identified.\u00a0The study was conducted in accordance with the Helsinki Declaration of 1964 and its later amendments. This manuscript does not contain any material from third parties requiring permission for publication. No individual patient data, medical records, or identifiable information were collected, used, or presented in this study. Accordingly, patient consent for publication was not required.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}